New asthma drug TR4 enters first human tests
Disease control
Completed
This early-stage study tested a new drug called TR4 in 12 adults with mild-to-moderate asthma. TR4 is a beta-2 blocker, which works differently than typical asthma treatments. The main goal was to see if it is safe and tolerable, and to measure its effects on lung function and ai…
Phase: PHASE1 • Sponsor: Trio Medicines Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC